Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)
CAPS Rating:
A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.
Growing the love for investing
A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Only negatives on the horizon